Home Newsfeeds DICE Therapeutics Q2 EPS $(0.58)

DICE Therapeutics Q2 EPS $(0.58)

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.

byBenzinga Newsdesk

August 11, 2022

1 minute read

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.

AI Demand Fuels TSMC’s Earnings, Offering a Beacon of Hope in Semiconductor Slump

By Anusuya Lahiri

October 6, 8:09 AM

Taiwan Semiconductor Manufacturing Company Ltd (NYSE: TSM), a key supplier to tech giants like Apple Inc (NASDAQ: AAPL) and Nvidia Corp (NASDAQ:

AAPL

Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion

By Lara Goldstein

July 22, 12:47 PM

Delic Holdings Corp. (OTCQB: DELCF) owns and operates an umbrella of psychedelics-related businesses towards improving access to health benefits across the U.S., including one of the largest chain of psychedelic wellness clinics in the country, Ketamine Wellness Centers (KWC).

DELCF

Peter Schiff Says ‘Still Don’t Get’ Logic Of Investors Buying Tech Stocks: Recommends These Instead

By Shanthi Rexaline

November 11, 7:57 AM

Given that tech stocks were the hardest hit in the current bear market, it is no wonder they led the recovery on Thursday. One economist, at least, is not happy about investors flocking to tech stocks in droves.

AAPL

Earnings

Recap: MetLife Q1 Earnings

By Benzinga Insights

May 3, 4:33 PM

MetLife (NYSE:MET) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:15 PM. Here’s what investors…

MET

DICE Therapeutics Q2 EPS $(0.58)

Related Posts

AI Demand Fuels TSMC’s Earnings, Offering a Beacon of Hope in Semiconductor Slump

Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion

Peter Schiff Says ‘Still Don’t Get’ Logic Of Investors Buying Tech Stocks: Recommends These Instead

Recap: MetLife Q1 Earnings